Search

Changhua H Ji

from San Diego, CA
Age ~62
Get Report
Also known as:
Changhua Hua Ji, Chang Hua Ji, Chang Yun Ji, Changhua Hua Jichang, Chang H Ji, Chang-Hua Ji, Hua Ji Changhua, Changua Ji, Hua Ji Chang
Related to:
John Yick Chung Leong, 75
Connected to:
Abraham Ji, 67Andy Ji, 27Chanda R Ji, 33Chanhong Ji, 47Dae Ji, 52Daisy Ji, 33Erika Y Ji, 32Haixia Ji, 42Huan G Ji, 56Jacky Ji, 54

Changhua Ji Phones & Addresses

  • San Diego, CA
  • Groton, CT
  • 31 North Dr, Livingston, NJ 07039 (973) 992-0569
  • Cupertino, CA
  • Los Altos, CA
  • Miami, FL
  • 12825 Via Nieve UNIT 48, San Diego, CA 92130

Work

Position: Protective Service Occupations

Education

Degree: Associate degree or higher

Publications

Us Patents

Aspgr Antibodies And Uses Thereof

View page
US Patent:
20210324085, Oct 21, 2021
Filed:
Nov 23, 2020
Appl. No.:
17/102112
Inventors:
- Schlieren, CH
Changhua Ji - Livingston NJ, US
Ekkehard Moessner - Kreuzlingen, CH
Pablo Umana - Wollerau, CH
International Classification:
C07K 16/28
C07K 14/56
Abstract:
The present invention generally relates to antibodies specific for asialoglycoprotein receptor (ASGPR) and their use for selectively delivering effector moieties that influence cellular activity. In addition, the present invention relates to polynucleotides encoding such antibodies, and vectors and host cells comprising such polynucleotides. The invention further relates to methods for producing the antibodies of the invention, and to methods of using them in the treatment of disease.

Aspgr Antibodies And Uses Thereof

View page
US Patent:
20200102392, Apr 2, 2020
Filed:
Aug 9, 2019
Appl. No.:
16/537038
Inventors:
- Schlieren, CH
Changhua Ji - Livingston NJ, US
Ekkehard Moessner - Kreuzlingen, CH
Pablo Umana - Wollerau, CH
International Classification:
C07K 16/28
C07K 14/56
Abstract:
The present invention generally relates to antibodies specific for asialoglycoprotein receptor (ASGPR) and their use for selectively delivering effector moieties that influence cellular activity. In addition, the present invention relates to polynucleotides encoding such antibodies, and vectors and host cells comprising such polynucleotides. The invention further relates to methods for producing the antibodies of the invention, and to methods of using them in the treatment of disease.

Aspgr Antibodies And Uses Thereof

View page
US Patent:
20190031760, Jan 31, 2019
Filed:
Sep 14, 2018
Appl. No.:
16/131110
Inventors:
- Schlieren, CH
Changhua Ji - Livingston NJ, US
Ekkehard Moessner - Kreuzlingen, CH
Pablo Umana - Wollerau, CH
Assignee:
ROCHE GLYCART AG - Toyota-shi
International Classification:
C07K 16/28
C07K 14/56
Abstract:
The present invention generally relates to antibodies specific for asialoglycoprotein receptor (ASGPR) and their use for selectively delivering effector moieties that influence cellular activity. In addition, the present invention relates to polynucleotides encoding such antibodies, and vectors and host cells comprising such polynucleotides. The invention further relates to methods for producing the antibodies of the invention, and to methods of using them in the treatment of disease.

Aspgr Antibodies And Uses Thereof

View page
US Patent:
20180118833, May 3, 2018
Filed:
Sep 21, 2017
Appl. No.:
15/711495
Inventors:
- Schlieren, CH
Changhua Ji - Livingston NJ, US
Ekkehard Moessner - Kreuzlingen, CH
Pablo Umana - Wollerau, CH
Assignee:
ROCHE GLYCART AG - Ottawa
International Classification:
C07K 16/28
C07K 14/56
Abstract:
The present invention generally relates to antibodies specific for asialoglycoprotein receptor (ASGPR) and their use for selectively delivering effector moieties that influence cellular activity. In addition, the present invention relates to polynucleotides encoding such antibodies, and vectors and host cells comprising such polynucleotides. The invention further relates to methods for producing the antibodies of the invention, and to methods of using them in the treatment of disease.

Asgpr Antibodies And Uses Thereof

View page
US Patent:
20150299324, Oct 22, 2015
Filed:
Aug 6, 2013
Appl. No.:
14/419824
Inventors:
- Schlieren, CH
Changhua Ji - Livingston NJ, US
Ekkehard Moessner - Kreuzlingen, CH
Pablo Umana - Wollerau, CH
Assignee:
ROCHE GLYCART AG - Schlieren
International Classification:
C07K 16/28
C07K 14/56
Abstract:
The present invention generally relates to antibodies specific for asialoglycoprotein receptor (ASGPR) and their use for selectively delivering effector moieties that influence cellular activity. In addition, the present invention relates to polynucleotides encoding such antibodies, and vectors and host cells comprising such polynucleotides. The invention further relates to methods for producing the antibodies of the invention, and to methods of using them in the treatment of disease.
Control profile
Changhua H Ji from San Diego, CA, age ~62 Get Report